1Zhao-You Tang Liver Cancer Institute & Zhongshan Hospital of Fudan University Professor of Surgery Chairman.Liver Cancer Institute of Fudan University(previous Liver Cancer Institute of Shanghai Medical University)136 Yixueyuan Road,Zhongshan Hospital,Shanghai 200032,China..Hepatocellular Carcinoma-Cause,Treatment and Metastasis[J].World Journal of Gastroenterology,2001,7(4):445-454. 被引量:214
5Houlston RS.What could we do now:molecular pathology of colorectal cancer[J].J Clin Pathol Mol,2001,54(4):206-221.
6LabinacaR,Mosconi S,Carassino MC.New strategies in colon cancer adjuvant therapy[J].Annals of Oncology,2006,17(7):51-54.
7Biedler JL.Genetic aspects of multidrug resistance[J].Cancer,1992,70(6):1799-1809.
8Qzwls RF.Clinical reversal of drug resistance[J].Curr Probl Cancer,1995,19(2):93.
9Moins N,Checillard S,Maublant J,et al.Effect of MDR reversing agent combinations on the 3Hdaunomycin accumulation in drug sensitive and drug-resistant human cancer cells[J].Anticancer Res,2000,20(4):2617-2623.
10Dale IL,Tuffley H,Stewart AJ,et al.Reversal of P-glycoprotein mediated multidrug resistance by XR9051,a novel diketopiperazine derjvative[J].Br J Cancer,1998,78(7):885-892.